- PR Newswire•11 hours agoAllergan Introduces RESTASIS MULTIDOSE™ (Cyclosporine Ophthalmic Emulsion) 0.05%, a New Delivery System for the One and Only FDA Approved Treatment to Help Patients Produce More of Their Own Tears
DUBLIN, Oct. 28, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for RESTASIS MULTIDOSE™ (Cyclosporine Ophthalmic ...
- Zacks•11 hours ago
Third quarter earnings season is in full flow with several companies like Lilly (LLY), Merck, Bristol-Myers, Novartis and others reporting results this week.
Allergan plc (AGN)
NYSE - NYSE Delayed Price. Currency in USD
|Bid||212.47 x 100|
|Ask||214.56 x 100|
|Day's Range||212.34 - 220.73|
|52wk Range||195.50 - 322.68|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||20.32|
|Avg Vol (3m)||3,216,841|
|Dividend & Yield||N/A (N/A)|